Eiger BiopharmaceuticalsEIGRQ
13F holders, Q3 2024 (September 30)1holders −1
0new positions
1sold out
$8.50avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Eiger Biopharmaceuticals Inc. (EIGRQ) in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holder was Propel Bio Management, LLC ($1.2M).
- Company
- Eiger Biopharmaceuticals Inc.
- CUSIP
- 28249U204
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $543 |
All 13F filers, Q2 2024 → Q3 2024: 43 shares sold, net −43 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Propel Bio Management, LLC | 0.72% | No change | 146,381 | $1.2M |
"% of holder's portfolio" is EIGRQ's weight in each manager's 13F, not the share of Eiger Biopharmaceuticals Inc. the manager owns.